Posts

Showing posts with the label Long-term planning

Focusing Short Term and Expecting Long Term – Asrar Qureshi’s Blog Post #842

Image
Focusing Short Term and Expecting Long Term – Asrar Qureshi’s Blog Post #842 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #842 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Diva Palavalaguna Photo Credit: RDNE Stock Project Photo Credit: Thirdman James Heskett is UPS Foundation Professor Emeritus at the Harvard Business School. He is a regular contributor to HBS Working Knowledge, and his articles are always deeply thought provoking. Primary thought for this post comes from his August 2023 article titled ‘As Leaders, Why Do We Continue to Reward A, While Hoping for B?’. (Link at the end). His article focuses on corporates, which I shall take up in this post with particular reference to the working in Pharma Industry. ...

Pakistan Pharma Industry SWOT – Part 31 – Asrar Qureshi’s Blog Post #622

Image
Pakistan Pharma Industry SWOT – Part 31 – Asrar Qureshi’s Blog Post #622 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #622 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 marked my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were started about four and a half years ago, I have covered several topics related to Pakistan Pharma Industry. This multi-part series shall do and review the SWOT – Strengths, Weaknesses, Opportunities, Threats – of the Pharma Industry. STRATEGIES It is now time to ...